A novel subtype to predict prognosis and treatment response with DNA driver methylation–transcription in ovarian cancer.
TableS1. Clinical data of ovarian cancer patients from TCGA and ICGC.
TableS2.Identified DNA driver methylation (DNAme) in TCGA, ICGC and GSE146556.
TableS3. The correlation between DNAme and corresponding mRNA expression in TCGA, ICGC and GSE146556.
TableS4.Analysis of pathway enrichment (KEGG) and Gene Ontology (GO) of DNAme-associated mRNA in TCGA.
TableS5. Univariate Cox regression analysis of DNAme-associated mRNA. (P < 0.05)
TableS6. Analysis of pathway enrichment (KEGG) and Gene Ontology (GO) of prognostic significance DNAme-associated mRNA in TCGA.
TableS7.Clinicopathological information of DNAme-associated subtypes in TCGA
TableS8.Gene set enrichment analysis (GSEA) of three subtypes in TCGA
Table S9. Abbreviations list